HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
29 hedge funds and large institutions have $12M invested in Hepion Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+17
Holders Change %
+141.67%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
4
Reduced
2
Closed
6
Calls
$657K
Puts
$562K
Net Calls
+$95K
Net Calls Change
+$137K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.79M |
2 |
BlackRock
New York
|
+$2.48M |
3 |
Renaissance Technologies
New York
|
+$721K |
4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$512K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$408K |